BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28478528)

  • 1. Creating a Simian Model of Guam ALS/PDC Which Reflects Chamorro Lifetime BMAA Exposures.
    Banack SA; Cox PA
    Neurotox Res; 2018 Jan; 33(1):24-32. PubMed ID: 28478528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain.
    Cox PA; Davis DA; Mash DC; Metcalf JS; Banack SA
    Proc Biol Sci; 2016 Jan; 283(1823):. PubMed ID: 26791617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. l-Serine Reduces Spinal Cord Pathology in a Vervet Model of Preclinical ALS/MND.
    Davis DA; Cox PA; Banack SA; Lecusay PD; Garamszegi SP; Hagan MJ; Powell JT; Metcalf JS; Palmour RM; Beierschmitt A; Bradley WG; Mash DC
    J Neuropathol Exp Neurol; 2020 Apr; 79(4):393-406. PubMed ID: 32077471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of BMAA neurotoxicity: a critical review.
    Karamyan VT; Speth RC
    Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.
    Cox PA; Banack SA; Murch SJ
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13380-3. PubMed ID: 14612559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
    Ince PG; Codd GA
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do vervets and macaques respond differently to BMAA?
    Cox PA; Davis DA; Mash DC; Metcalf JS; Banack SA
    Neurotoxicology; 2016 Dec; 57():310-311. PubMed ID: 27133441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
    Bradley WG; Mash DC
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
    Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
    J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
    Murch SJ; Cox PA; Banack SA; Steele JC; Sacks OW
    Acta Neurol Scand; 2004 Oct; 110(4):267-9. PubMed ID: 15355492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMAA and Neurodegenerative Illness.
    Cox PA; Kostrzewa RM; Guillemin GJ
    Neurotox Res; 2018 Jan; 33(1):178-183. PubMed ID: 28540663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam.
    Duncan MW; Steele JC; Kopin IJ; Markey SP
    Neurology; 1990 May; 40(5):767-72. PubMed ID: 2330104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam.
    Murch SJ; Cox PA; Banack SA
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12228-31. PubMed ID: 15295100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros.
    Kisby GE; Ellison M; Spencer PS
    Neurology; 1992 Jul; 42(7):1336-40. PubMed ID: 1620343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam.
    Banack SA; Cox PA
    Neurology; 2003 Aug; 61(3):387-9. PubMed ID: 12913204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-BMAA induced ER stress and enhanced caspase 12 cleavage in human neuroblastoma SH-SY5Y cells at low nonexcitotoxic concentrations.
    Okle O; Stemmer K; Deschl U; Dietrich DR
    Toxicol Sci; 2013 Jan; 131(1):217-24. PubMed ID: 23047912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis.
    Stommel EW; Field NC; Caller TA
    Med Hypotheses; 2013 Feb; 80(2):142-5. PubMed ID: 23246360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple neurotoxic items in the Chamorro diet link BMAA with ALS/PDC.
    Banack SA; Murch SJ
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():34-40. PubMed ID: 19929729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal infusion of BMAA induces selective motor neuron damage and astrogliosis in the ventral horn of the spinal cord.
    Yin HZ; Yu S; Hsu CI; Liu J; Acab A; Wu R; Tao A; Chiang BJ; Weiss JH
    Exp Neurol; 2014 Nov; 261():1-9. PubMed ID: 24918341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMAA selectively injures motor neurons via AMPA/kainate receptor activation.
    Rao SD; Banack SA; Cox PA; Weiss JH
    Exp Neurol; 2006 Sep; 201(1):244-52. PubMed ID: 16764863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.